Candida albicans infections in renal transplant recipients: Effect of caspofungin on polymorphonuclear cells

4Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study aimed to compare the caspofungin immunomodulating activities against Candida albicans on polymorphonuclear cells (PMNs) from renal transplant recipients (RTRs) and healthy subjects (HSs). RTR PMNs showed a significantly reduced fungicidal activity compared with that of HS PMNs. Addition of caspofungin to RTR PMNs significantly potentiated the yeast intracellular killing rate, achieving values similar to those observed for HS PMNs. These data show that caspofungin is suitable for invasive candidiasis treatment in patients with immune system-impaired components. Copyright © 2011, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Allizond, V., Banche, G., Giacchino, F., Merlino, C., Scalas, D., Tullio, V., … Cuffini, A. M. (2011). Candida albicans infections in renal transplant recipients: Effect of caspofungin on polymorphonuclear cells. Antimicrobial Agents and Chemotherapy, 55(12), 5936–5938. https://doi.org/10.1128/AAC.00521-11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free